PharmaNews.eu
  • Home
  • Business
  • R&D
  • EC
  • EMA
  • Events
  • Open Calls

Pfizer

Pfizer

PfizerFounded in 1849, Pfizer is the world's largest research-based pharmaceutical company. Pfizer is taking new approaches to advancing better health as it discovers, develops, manufactures and delivers quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. Pfizer also partners with healthcare providers, governments and local communities around the world to expand access to medicines and to provide better quality health care and health system support. At Pfizer, more than 84,000 colleagues in more than 90 countries work every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide. For more information visit www.pfizer.com.

Pfizer RSS Channel

Filters
List of articles in category Pfizer
Title Published Date
Pfizer invests $43 billion to battle cancer 13 March 2023
Pfizer announces The Lancet Neurology has published Phase 3 data for zavegepant for the acute treatment of migraine in adults 17 February 2023
Pfizer reports record full-year 2022 results 02 February 2023
Pfizer expands 'An Accord for a Healthier World' product offering to include full portfolio for greater benefit to 1.2 billion people in 45 lower-income countries 18 January 2023
Pfizer announces FDA and EMA acceptance of etrasimod regulatory submissions for ulcerative colitis 26 December 2022
Pfizer and BioNTech report new data on Omicron BA.4/BA.5-adapted bivalent booster 24 November 2022
Pfizer and BioNTech receive positive CHMP opinion for Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine booster for children 5 through 11 years of age in European Union 11 November 2022
Pfizer and BioNTech announce positive early data from clinical trial of Omicron BA.4/BA.5-adapted bivalent booster in individuals 18 years and older 25 October 2022
Pfizer to supply Global Fund up to 6 million PAXLOVID™ treatment courses for low-and-middle-income countries 22 September 2022
Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare hematology 08 August 2022
Pfizer and BioNTech complete submission to European Medicines Agency for Omicron BA.1 adapted bivalent vaccine candidate 20 July 2022
Pfizer and BioNTech announce Omicron-adapted COVID-19 vaccine candidates demonstrate high immune response against Omicron 25 June 2022
Pfizer to acquire Biohaven Pharmaceuticals 10 May 2022
Pfizer shares top-line results from Phase 2/3 EPIC-PEP study of PAXLOVID™ for post-exposure prophylactic use 02 May 2022
Pfizer updates company position in Russia 16 March 2022
Pfizer receives CHMP positive opinion for novel COVID-19 oral treatment 01 February 2022
Pfizer and BioNTech initiate study to evaluate Omicron-based COVID-19 vaccine in adults 18 to 55 years of age 27 January 2022
Pfizer and BioNTech publish data from two laboratory studies on COVID-19 vaccine-induced antibodies ability to neutralize SARS-CoV-2 Omicron variant 25 January 2022
Pfizer shares in vitro efficacy of novel COVID-19 oral treatment against omicron variant 19 January 2022
Pfizer and BioNTech provide update on Omicron variant 08 December 2021

Page 1 of 6

  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next
  • End
  1. You are here:  
  2. Home
  3. Pfizer

About

  • Home
  • Terms and Conditions
  • Contact

Advertise

Top News Channels

  • Business
  • Research
  • EMA
  • Events

Follow us

Didn't we got you connected? If not, please note the following magic buttons:

  • Facebook
  • Twitter
  • RSS 2.0
  • Atom 1.0

Newsletter

Stay updated on the latest Pharma News. Subscribe now, it's free!

Copyright © 2023 PharmaNews.eu. All Rights Reserved.